Examen de radiation de la TSX – Acerus Pharmaceuticals Corporation. (ASP, ASP.WT)
Issuer: | Acerus Pharmaceuticals Corporation |
Securities: | Common shares Common share purchase warrants |
Symbol(s): | ASP ASP.WT |
Delisting Review Type: | Remedial |
Delisting Review Period: | 120 days to regain compliance with continued listing requirements. |
TSX contact: | Chris Birkett, Director, Toronto Stock Exchange. |